Principal Financial Group Inc Neurocrine Biosciences Inc Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q4 2024

A detailed history of Principal Financial Group Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 252,469 shares of NBIX stock, worth $30.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
252,469
Holding current value
$30.1 Million
% of portfolio
0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$111.62 - $139.44 $28.2 Million - $35.2 Million
252,469 New
252,469 $34.5 Million
Q3 2024

Oct 31, 2024
SELL
$114.58 - $153.15 $13.8 Million - $18.5 Million
-120,576 Reduced 32.26%
253,186 $29.1 Million
Q2 2024

Jul 29, 2024
SELL
$130.86 - $143.19 $5.88 Million - $6.43 Million
-44,913 Reduced 10.73%
373,762 $51.5 Million
Q1 2024

Apr 29, 2024
BUY
$130.4 - $143.74 $56,072 - $61,808
430 Added 0.1%
418,675 $57.7 Million
Q4 2023

Feb 07, 2024
BUY
$106.07 - $132.76 $4.27 Million - $5.35 Million
40,289 Added 10.66%
418,245 $55.1 Million
Q3 2023

Nov 02, 2023
SELL
$94.02 - $117.1 $562,051 - $700,023
-5,978 Reduced 1.56%
377,956 $42.5 Million
Q2 2023

Aug 07, 2023
SELL
$89.53 - $104.87 $326,605 - $382,565
-3,648 Reduced 0.94%
383,934 $36.2 Million
Q1 2023

May 09, 2023
SELL
$94.11 - $123.02 $1.23 Million - $1.61 Million
-13,082 Reduced 3.27%
387,582 $39.2 Million
Q4 2022

Feb 09, 2023
BUY
$106.72 - $127.06 $1.24 Million - $1.48 Million
11,659 Added 3.0%
400,664 $47.9 Million
Q3 2022

Nov 09, 2022
SELL
$92.03 - $107.81 $322,289 - $377,550
-3,502 Reduced 0.89%
389,005 $41.3 Million
Q2 2022

Aug 10, 2022
BUY
$75.79 - $100.07 $5.12 Million - $6.76 Million
67,568 Added 20.79%
392,507 $38.3 Million
Q1 2022

May 09, 2022
SELL
$72.45 - $94.81 $255,024 - $333,731
-3,520 Reduced 1.07%
324,939 $30.5 Million
Q4 2021

Feb 09, 2022
SELL
$79.65 - $106.22 $263,880 - $351,906
-3,313 Reduced 1.0%
328,459 $28 Million
Q3 2021

Nov 09, 2021
SELL
$86.18 - $99.03 $169,516 - $194,792
-1,967 Reduced 0.59%
331,772 $31.8 Million
Q2 2021

Aug 10, 2021
BUY
$89.43 - $102.27 $528,710 - $604,620
5,912 Added 1.8%
333,739 $32.5 Million
Q1 2021

May 10, 2021
BUY
$87.57 - $119.4 $27.7 Million - $37.8 Million
316,575 Added 2813.5%
327,827 $31.9 Million
Q4 2020

Feb 08, 2021
SELL
$86.91 - $108.33 $31,461 - $39,215
-362 Reduced 3.12%
11,252 $1.08 Million
Q3 2020

Nov 06, 2020
SELL
$96.16 - $135.15 $199,243 - $280,030
-2,072 Reduced 15.14%
11,614 $1.12 Million
Q2 2020

Aug 05, 2020
BUY
$85.09 - $130.36 $286,668 - $439,182
3,369 Added 32.65%
13,686 $1.67 Million
Q1 2020

May 12, 2020
BUY
$75.11 - $113.76 $30,044 - $45,504
400 Added 4.03%
10,317 $893,000
Q4 2019

Feb 05, 2020
SELL
$86.8 - $118.57 $4.1 Million - $5.59 Million
-47,178 Reduced 82.63%
9,917 $1.07 Million
Q3 2019

Nov 13, 2019
BUY
$83.82 - $101.5 $199,575 - $241,671
2,381 Added 4.35%
57,095 $5.15 Million
Q2 2019

Aug 12, 2019
BUY
$72.24 - $91.27 $37,492 - $47,369
519 Added 0.96%
54,714 $4.62 Million
Q1 2019

May 10, 2019
BUY
$69.31 - $91.53 $693 - $915
10 Added 0.02%
54,195 $4.78 Million
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $2.04 Million - $3.71 Million
-29,816 Reduced 35.49%
54,185 $3.87 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $799,148 - $1.02 Million
-8,082 Reduced 8.78%
84,001 $10.3 Million
Q2 2018

Aug 13, 2018
BUY
$75.3 - $105.99 $988,463 - $1.39 Million
13,127 Added 16.63%
92,083 $0
Q1 2018

May 14, 2018
BUY
$75.88 - $92.43 $93,635 - $114,058
1,234 Added 1.59%
78,956 $6.55 Million
Q4 2017

Feb 13, 2018
BUY
$58.53 - $77.59 $51,623 - $68,434
882 Added 1.15%
77,722 $6.03 Million
Q3 2017

Nov 02, 2017
BUY
$47.97 - $61.28 $3.69 Million - $4.71 Million
76,840
76,840 $4.71 Million

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email